[
      {
            "id": 1,
            "name": "Benzodiazepines",
            "learnItems":[
                  {
                        "title":"SAR Requirements",  
                        "name" : "Hover over the compound to learn about the SAR Characteristics",
                        "imagePath" : "slide-4a.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "Ring A",
                                    "y": 263,
                                    "x": 292,
                                    "size": 40,
                                    "color": "red",
                                    "text": "Pi-Pi stacking with BZR"
                              },
                              {
                                    "name": "Ring B",
                                    "y": 280,
                                    "x": 203,
                                    "size": 30,
                                    "color": "green",
                                    "text": "H-bond acceptor (O, N, S) or N-heterocycle required. 1,2 annelation (N-heterocycle) increases affinity for BZR"
                              },
                              {
                                    "name": "N1",
                                    "y": 209,
                                    "x": 266,
                                    "size": 30,
                                    "color": "blue",
                                    "text": "EWG increases activity"
                              },
                              {
                                    "name": "C7",
                                    "y": 317,
                                    "x": 154,
                                    "size": 30,
                                    "color": "orange",
                                    "text": "methyl group preferred; bulky group decreases activity because it prevents binding to BZR"
                              },
                              {
                                    "name": "Ring C",
                                    "y": 411,
                                    "x": 288,
                                    "size": 30,
                                    "color": "deeppink",
                                    "text": "Hydrophobic interaction with BZR"
                              },
                              {
                                    "name": "C2",
                                    "y": 375,
                                    "x": 340,
                                    "size": 25,
                                    "color": "brown",
                                    "text": "F or Cl substitution reduces aromatic hydroxylation and improves half-life"
                              },
                              {
                                    "name": "C4",
                                    "y": 466,
                                    "x": 288,
                                    "size": 25,
                                    "color": "darkgoldenrod",
                                    "text": "steric repulsion occurs with para substituent"
                              }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Example Compound 2",
                        "imagePath" : "slide-4b.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "Ring A",
                                    "y": 291,
                                    "x": 292,
                                    "size": 40,
                                    "color": "red",
                                    "text": "Pi-Pi stacking with BZR"
                              },
                              {
                                    "name": "Ring B",
                                    "y": 305,
                                    "x": 203,
                                    "size": 30,
                                    "color": "green",
                                    "text": "H-bond acceptor (O, N, S) or N-heterocycle required. 1,2 annelation (N-heterocycle) increases affinity for BZR"
                              },
                              {
                                    "name": "N1",
                                    "y": 241,
                                    "x": 266,
                                    "size": 30,
                                    "color": "blue",
                                    "text": "EWG increases activity"
                              },
                              {
                                    "name": "C7",
                                    "y": 345,
                                    "x": 159,
                                    "size": 30,
                                    "color": "orange",
                                    "text": "methyl group preferred; bulky group decreases activity because it prevents binding to BZR"
                              },
                              {
                                    "name": "Ring C",
                                    "y": 440,
                                    "x": 291,
                                    "size": 30,
                                    "color": "deeppink",
                                    "text": "Hydrophobic interaction with BZR"
                              },
                              {
                                    "name": "C2",
                                    "y": 410,
                                    "x": 340,
                                    "size": 25,
                                    "color": "brown",
                                    "text": "F or Cl substitution reduces aromatic hydroxylation and improves half-life"
                              },
                              {
                                    "name": "C4",
                                    "y": 490,
                                    "x": 288,
                                    "size": 25,
                                    "color": "darkgoldenrod",
                                    "text": "steric repulsion occurs with para substituent"
                              }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Hover over Lorazepam to learn about the SAR Characteristics",
                        "imagePath" : "slide-5a.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "Ring A",
                                    "y": 227,
                                    "x": 209,
                                    "size": 30,
                                    "color": "red",
                                    "text": "Pi-Pi stacking with BZR"
                              },
                              {
                                    "name": "Ring B",
                                    "y": 158,
                                    "x": 291,
                                    "size": 30,
                                    "color": "green",
                                    "text": "H-bond acceptor (O, N, S) or N-heterocycle required. 1,2 annelation (N-heterocycle) increases affinity for BZR"
                              },
                              {
                                    "name": "N1",
                                    "y": 164,
                                    "x": 223,
                                    "size": 30,
                                    "color": "blue",
                                    "text": "EWG increases activity"
                              },
                              {
                                    "name": "C7",
                                    "y": 264,
                                    "x": 159,
                                    "size": 30,
                                    "color": "orange",
                                    "text": "methyl group preferred; bulky group decreases activity because it prevents binding to BZR"
                              },
                              {
                                    "name": "Ring C",
                                    "y": 310,
                                    "x": 263,
                                    "size": 30,
                                    "color": "deeppink",
                                    "text": "Hydrophobic interaction with BZR"
                              },
                              {
                                    "name": "C3",
                                    "y": 202,
                                    "x": 335,
                                    "size": 25,
                                    "color": "purple",
                                    "text": "OH group eliminates first pass metabolism as the hydroxyl acts as a “handle” for conjugation."
                              },
                              {
                                    "name": "C2",
                                    "y": 279,
                                    "x": 319,
                                    "size": 25,
                                    "color": "brown",
                                    "text": "F or Cl substitution reduces aromatic hydroxylation and improves half-life"
                              }
                        ],
                        "colorLocationAssociations" : [
                              {"color": "red", "location": "Ring A", "description" : "Ring A: Pi-Pi stacking with BZR" },
                              {"color": "orange", "location": "C7", "description" : "C7: EWG increases activity" },
                              {"color": "green", "location": "Ring B", "description" : "Ring B:  H-bond acceptor (O, N, S) or N-heterocycle required 1,2 annelation (N-heterocycle) increases affinity for BZR" },
                              {"color": "blue", "location": "N1", "description" : "N1: methyl group preferred; bulky group decreases activity because it prevents binding to BZR" },
                              {"color": "purple", "location": "C3", "description" : "C3: OH group eliminates first pass metabolism as the hydroxyl acts as a “handle” for conjugation." },
                              {"color": "deeppink", "location": "Ring C", "description" : "Ring C: Hydrophobic interaction with BZR" },
                              {"color": "darkgoldenrod", "location": "C4", "description" : "C4: Steric repulsion occurs with para substituent " },
                              {"color": "teal", "location": "C2", "description" : "C2:  F or Cl substitution reduces aromatic hydroxylation and improves half-life" }
                        ]
                  },
                  {
                        "title":"SAR Requirements",
                        "name" : "Hover over Alprazolam to learn about the SAR Characteristics",
                        "imagePath" : "slide-5b.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "Ring A",
                                    "y": 276,
                                    "x": 229,
                                    "size": 50,
                                    "color": "red",
                                    "text": "Pi-Pi stacking with BZR"
                              },
                              {
                                    "name": "Ring B",
                                    "y": 197,
                                    "x": 303,
                                    "size": 50,
                                    "color": "green",
                                    "text": "H-bond acceptor (O, N, S) or N-heterocycle required. 1,2 annelation (N-heterocycle) increases affinity for BZR"
                              },
                              {
                                    "name": "N1",
                                    "y": 178,
                                    "x": 223,
                                    "size": 30,
                                    "color": "blue",
                                    "text": "EWG increases activity"
                              },
                              {
                                    "name": "C7",
                                    "y": 328,
                                    "x": 165,
                                    "size": 40,
                                    "color": "orange",
                                    "text": "methyl group preferred; bulky group decreases activity because it prevents binding to BZR"
                              },
                              {
                                    "name": "Ring C",
                                    "y": 384,
                                    "x": 300,
                                    "size": 50,
                                    "color": "deeppink",
                                    "text": "Hydrophobic interaction with BZR"
                              }
                        ]
                  },
                  {
                        "title":"SAR Practice Problem",
                        "name" : "Activity Change",
                        "imagePath" : "slide7-transition.jpg",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity?",
                        "options" : [
                              "Increase",
                              "Decrease",
                              "No Effect"
                        ],
                        "answer" : "Decrease",
                        "explanation" : "Addition of a bulky group at N1 prevents binding to the BZR; methyl group is preferred"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide8.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Increase",
                        "explanation" : "Addition of Cl to position 2 reduces aromatic hydroxylation (phase one P450 metabolism) and increases half-life"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide10.PNG",
                        "question" : "Which of these 3 compounds would be the best benzodiazepine for use as a hypnotic?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 1",
                        "explanation" : "It already has the hydroxyl handle (position 3) so it is quickly metabolized to an inactive metabolite by conjugation; thus it has a short elimination half-life, which is ideal for hypnotics"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide11.PNG",
                        "question" : "Which of these 3 compounds would be the best benzodiazepine for use as an anxiolytic?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 2",
                        "explanation" : "The compound is slowly absorbed because it has a carboxylic acid that must be cleaved first (like a prodrug) and it is metabolized to an active metabolite; thus it has a long elimination half-life (40-50 hr), which is ideal for anxiolytics"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide13.PNG",
                        "question" : "Predict whether the metabolites will be active or inactive for the compounds (2, 3) and Conjugated Products",
                        "options" : [ 
                              "Active, Active, Inactive",
                              "Active, Inactive, Inactive", 
                              "Inactive, Inactive, Active",
                              "Inactive, Active, Inactive"
                        ],
                        "answer" : "Active, Active, Inactive",
                        "explanation" : ""
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide14.PNG",
                        "question" : "Would compound 1 (temazepam) be an ideal hypnotic or anxiolytic? Predict whether the metabolites will be active or inactive for compound 2",
                        "options" : [
                              "Anxiolytic, Active",
                              "Anxiolytic, Inactive",
                              "Hypnotic, Inactive",
                              "Hypnotic, Active"
                        ],
                        "answer" : "Hypnotic, Inactive",
                        "explanation" : ""
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide15.PNG",
                        "question" : "Would compound 1 (triazolam) be an ideal hypnotic or anxiolytic? Predict whether the metabolites will be active or inactive for the compounds (2, 3) and Conjugated Products",
                        "options" : [
                              "Anxiolytic, Active, Inactive, Inactive",
                              "Anxiolytic, Inactive, Active, Inactive",
                              "Hypnotic, Inactive, Active, Inactive",
                              "Hypnotic, Active, Inactive, Inactive"
                        ],
                        "answer" : "Hypnotic, Inactive, Active, Inactive",
                        "explanation" : ""
                  }
            ], 
            "testItems":[
                  {
                        "title":"Side-Effects",  
                        "question" : "Benzodiazepines act at _______ receptor to increase _______ channel opening:",
                        "options" : [ 
                              "GABA, Ca2+",
                              "GABA, Na+",
                              "GABA, Cl-",
                              "glutamate, Ca2+",
                              "glutamate, Na+",
                              "glutamate, Cl-"
                        ],
                        "answer" : "GABA, Cl-"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Benzodiazepines will be affected by the inhibitors or activators of",
                        "options" : [
                              "CYP2B6", 
                              "CYP3A4", 
                              "CYP2C9",
                              "C3PO"
                        ],
                        "answer" : "CYP3A4"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Diazepam and ______ are useful to treat withdrawal from _______",
                        "options" : [
                              "clonazepam, nicotine", 
                              "clonazepam, alcohol", 
                              "triazolam, opioids",
                              "triazolam, nicotine",
                              "midazolam, alcohol",
                              "midazolam, opioids",
                              "lorazepam, nicotine",
                              "lorazepam, alcohol"
                        ],
                        "answer" : "lorazepam, alcohol"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Lorazepam, ______, and ______ are all used to treat status epilepticus",
                        "options" : [
                              "clonazepam, midazolam", 
                              "clonazepam, triazolam", 
                              "diazepam, clonazepam",
                              "diazepam, midazolam"
                        ],
                        "answer" : "diazepam, clonazepam"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Patient Smith has been prescribed a benzodiazepine and another medication for OCD. Smith feels excessively sleepy and has noticed her balance is off. Smith is probably taking diazepam and",
                        "options" : [
                              "bupropion",
                              "nortriptyline",
                              "fluoxetine"
                        ],
                        "answer" : "bupropion"
                  },
                  {
                        "title":"Contraindication",  
                        "question" : "This benzodiazepine is best suited for elderly individuals with liver damage:",
                        "options" : [
                              "Lorazepam", 
                              "Diazepam", 
                              "Clonazepam"
                        ],
                        "answer" : "Lorazepam"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "An individual who takes benzodiazepine usually develops tolerance to",
                        "options" : [
                              "sedative effects", 
                              "anxiolytic effects", 
                              "anesthetic effects"
                        ],
                        "answer" : "sedative effects"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "When a benzodiazepine is taken for sleep, benzodiazepine's long elimination half life can cause:",
                        "options" : [
                              "headache", 
                              "insomnia", 
                              "grogginess",
                              "amnesia"
                        ],
                        "answer" : "grogginess"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "A serious and unusual side effect of a benzodiazepine is",
                        "options" : [
                              "Induction of P450s", 
                              "G6P deficiency", 
                              "amnesia"
                        ],
                        "answer" : "Induction of P450s"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "An individual who takes benzodiazepine rarely develops tolerance to",
                        "options" : [
                              "sedative effects", 
                              "anxiolytic effects", 
                              "anesthetic effects"
                        ],
                        "answer" : "anxiolytic effects"
                  }
            ],
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Diazepam", "imagePath": "diazepam.PNG" },
                              {"title": "Lorazepam", "imagePath": "lorazepam.PNG" }, 
                              {"title": "Temazepam", "imagePath": "temazepam.PNG" },
                              {"title": "Triazolam", "imagePath": "triazolam.PNG" },
                              {"title": "Midazolam", "imagePath": "midazolam.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Pharmokinetic",  
                        "sections" : [
                              {"title": "Absorption", "content": "" },
                              {"title": "Distribution", "content": "" }, 
                              {"title": "Metabolism", "content": "" },
                              {"title": "Excretion", "content": ""  }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "MOA", "imagePath": "moa.PNG" },
                              {"title": "Mechanism of Action", "content": "" },
                              {"title": "Pharmacological Action", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ],
            "exampleReview":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Diazepam (Long Acting)", "imagePath": "diazepam.PNG" },
                              {"title": "Lorazepam (Intermediate Acting)", "imagePath": "lorazepam.PNG" }, 
                              {"title": "Temazepam (Intermediate Acting)", "imagePath": "temazepam.PNG" },
                              {"title": "Triazolam (Short Acting)", "imagePath": "triazolam.PNG" },
                              {"title": "Midazolam (Short Acting)", "imagePath": "midazolam.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "Ring A", "content": "Pi-Pi stacking with BZR" },
                              {"title": "C7", "content": "EWG increases activity" }, 
                              {"title": "Ring B", "content": "H-bond acceptor (O, N, S) or N-heterocycle required 1,2 annelation (N-heterocycle) increases affinity for BZR" },
                              {"title": "N1", "content": "methyl group preferred; bulky group decreases activity because it prevents binding to BZR" },
                              {"title": "C3", "content": "OH group eliminates first pass metabolism as the hydroxyl acts as a “handle” for conjugation." },
                              {"title": "Ring C", "content": "Hydrophobic interaction with BZR" },
                              {"title": "C4", "content": "Steric repulsion occurs with para substituent" },
                              {"title": "C2", "content": "F or Cl substitution reduces aromatic hydroxylation and improves half-life" }
                        ]
                  },
                  {
                        "title": "Pharmokinetic",  
                        "sections" : [
                              {"title": "Absorption", "content": "When taken orally, most BZD show rapid and complete absorption from GI tract" },
                              {"title": "Distribution", "content": "-Increase lipophilicity = Increase rate of CNS distribution. -Cross BBB by passive diffusion." }, 
                              {"title": "Metabolism", "content": "-Do NOT induce metabolism of other drugs. -Liver metabolized to active compounds (except lorazepam)" },
                              {"title": "Excretion", "content": "By kidneys" },
                              {"title": "Duration of Action", "content": "[Short Acting]: 1.5-5 hours, Not converted into active intermediates. [Intermediate Acting]: 8-20 hours. [Long Acting]: 30-60 hours, Converted into active intermediates." }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "MOA", "imagePath": "moa.PNG" },
                              {"title": "Mechanism of Action", "content": "-Potentiates GABA by binding to allosteric site on receptor. Increase the frequency of Cl- channel opening. -Enhancement of GABA activity slows nerve impulses throughout the body, GABA produces calming effect in the brain." },
                              {"title": "Pharmacological Action", "content": "-Sedation (decrease latency and REM). -Reduction in muscle tone. -Tolerance develops after 1-2 weeks of use. -Reduction in anxiety." }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "Drowsiness, Fatigue, Amnesia, Ataxia" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "Anti-Epileptic (diazepam, lorazepam), Insomnia (temazepam, triazolam), Anti-anxiety (diazepam, lorazepam), Muscle spasms (diazepam), Anesthesia (diazepam, lorazepam, midazolam). *Duration of Action determines therapeutic use." }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "-Duration of action and elimination half life are NOT the same. -BZD increase frequency of Cl- channel opening. -GABA must be present for BZD to have effect. -Flumazenil = BZD receptor antagonist for treatment of acute overdose." }
                        ]
                  }
            ]
      },
      {
            "id": 2,
            "name": "Barbiturates",
            "learnItems":[
                  {
                        "title":"SAR Requirements",  
                        "name" : "Hover over the compound to learn about the SAR Characteristics",
                        "imagePath" : "slide26.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "N1",
                                    "y": 234,
                                    "x": 191,
                                    "size": 40,
                                    "color": "red",
                                    "text": "Must be a nitrogen and unsubstitued if N3 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "N3",
                                    "y": 234,
                                    "x": 307,
                                    "size": 40,
                                    "color": "orange",
                                    "text": "Must be a nitrogen and unsubstituted if N1 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "C2",
                                    "y": 164,
                                    "x": 250,
                                    "size": 40,
                                    "color": "green",
                                    "text": "Changing C=O → C=S increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 311,
                                    "x": 334,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 311,
                                    "x": 163,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "R1 & R2",
                                    "y": 365,
                                    "x": 253,
                                    "size": 55,
                                    "color": "deeppink",
                                    "text": "bulky carbon groups increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "5,5",
                                    "y": 300,
                                    "x": 250,
                                    "size": 30,
                                    "color": "goldenrod",
                                    "text": "distribution required for activity"
                              }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Disubstitution Required for Activity",
                        "imagePath" : "slide27a.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "N1", "description" : "Barbiturates can undergo enol-keto tautomerization, which gives them near neutral pkas (7.4). Less than 50% gets ionized, so good balance of solubility and CNS penetration." }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Disubstitution Required for Activity",
                        "imagePath" : "slide27b.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "N1", "description" : "Without any substitution at position 5, the acidic hydrogen gets deprotonated. Resonance stabilization leads to lower pka (4) and 99% ionization occurs, so unable to penetrate the CNS." }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Hover over Phenobarbital to learn about the SAR Characteristics",
                        "imagePath" : "slide28a.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "N1",
                                    "y": 218,
                                    "x": 180,
                                    "size": 40,
                                    "color": "red",
                                    "text": "Must be a nitrogen and unsubstitued if N3 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "N3",
                                    "y": 218,
                                    "x": 302,
                                    "size": 40,
                                    "color": "orange",
                                    "text": "Must be a nitrogen and unsubstituted if N1 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "C2",
                                    "y": 162,
                                    "x": 238,
                                    "size": 40,
                                    "color": "green",
                                    "text": "Changing C=O → C=S increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 294,
                                    "x": 162,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 294,
                                    "x": 314,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "R1 & R2",
                                    "y": 385,
                                    "x": 262,
                                    "size": 80,
                                    "color": "deeppink",
                                    "text": "bulky carbon groups increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "5,5",
                                    "y": 288,
                                    "x": 238,
                                    "size": 30,
                                    "color": "goldenrod",
                                    "text": "distribution required for activity"
                              }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Hover over Thiopental to learn about the SAR Characteristics",
                        "imagePath" : "slide28b.PNG",
                        "compoundHotspots" : [
                              {
                                    "name": "N1",
                                    "y": 210,
                                    "x": 174,
                                    "size": 40,
                                    "color": "red",
                                    "text": "Must be a nitrogen and unsubstitued if N3 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "N3",
                                    "y": 210,
                                    "x": 274,
                                    "size": 40,
                                    "color": "orange",
                                    "text": "Must be a nitrogen and unsubstituted if N1 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action."
                              },
                              {
                                    "name": "C2",
                                    "y": 160,
                                    "x": 222,
                                    "size": 40,
                                    "color": "green",
                                    "text": "Changing C=O → C=S increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 270,
                                    "x": 152,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "C4 & C6",
                                    "y": 270,
                                    "x": 294,
                                    "size": 40,
                                    "color": "blue",
                                    "text": "Must contain C=O"
                              },
                              {
                                    "name": "R1 & R2",
                                    "y": 364,
                                    "x": 234,
                                    "size": 80,
                                    "color": "deeppink",
                                    "text": "bulky carbon groups increases lipophilicity and more rapid onset of action"
                              },
                              {
                                    "name": "5,5",
                                    "y": 268,
                                    "x": 223,
                                    "size": 30,
                                    "color": "goldenrod",
                                    "text": "distribution required for activity"
                              }
                        ],
                        "colorLocationAssociations" : [
                              {"color": "red", "location": "N1", "description" : "N1: Must be a nitrogen and unsubstitued if N3 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action." },
                              {"color": "orange", "location": "N3", "description" : "N3: must be a nitrogen and unsubstituted if N1 is substituted. Carbon group substitution will increase lipophilicity and more rapid onset of action " },
                              {"color": "green", "location": "C2", "description" : "C2: changing C=O → C=S increases lipophilicity and more rapid onset of action" },
                              {"color": "blue", "location": "C4 & C6", "description" : "C4 & C6: must contain C=O" },
                              {"color": "deeppink", "location": "R1 & R2", "description" : "R1 & R2: bulky carbon groups increases lipophilicity and more rapid onset of action " }
                        ]
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "/compounds/slide7-transition.jpg",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Decrease",
                        "explanation" : "Changing C=S to C=O decreases lipophilicity and onset of action"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "/compounds/slide7-transition.jpg",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Increase",
                        "explanation" : "5,5- disubstitution needed for activity in order for CNS penetration"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "/compounds/slide10-3options.jpg",
                        "question" : "Which of these 3 compounds would be a CNS active barbiturate?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : "5,5- disubstitution and weak acid (N1 or N3 must be unsubstituted) are required for activity in order for CNS penetration"
                  }
            ],
            "testItems":[
                  {
                        "title":"Mechanism of Action",  
                        "question" : "Higher doses of barbiturates bind these receptors in the cerebellum",
                        "options" : [
                              "GABAa", 
                              "GABAb", 
                              "glutamate"
                        ],
                        "answer" : "GABAa"
                  },
                  {
                        "title":"Mechanism of Action",  
                        "question" : "The long half life of barbiturates causes this effect",
                        "options" : [
                              "hangover", 
                              "rebound"
                        ],
                        "answer" : "hangover"
                  },
                  {
                        "title":"Mechanism of Action",  
                        "question" : "The short half life or abrupt discontinuation of barbiturates causes this effect",
                        "options" : [
                              "hangover", 
                              "rebound"
                        ],
                        "answer" : "rebound"
                  },
                  {
                        "title":"Mechanism of Action",  
                        "question" : "Higher doses of barbiturates bind [ans] receptors in the cerebellum causing the side effect of",
                        "options" : [
                              "Ataxia", 
                              "amnesia", 
                              "sedation"
                        ],
                        "answer" : "sedation"
                  }
            ], 
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Diazepam", "content": "", "imagePath": "/molecular.PNG" },
                              {"title": "Lorazepam", "content": "", "imagePath": "/molecular.PNG" }, 
                              {"title": "Temazepam", "content": "", "imagePath": "/molecular.PNG" },
                              {"title": "Midazolam", "content": "", "imagePath": "/molecular.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Pharmokinetic",  
                        "sections" : [
                              {"title": "Absorption", "content": "" },
                              {"title": "Distribution", "content": "" }, 
                              {"title": "Metabolism", "content": "" },
                              {"title": "Excretion", "content": ""  }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "Mechanism of Action", "content": "" },
                              {"title": "Pharmacological Action", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ]
      },
      {
            "id": 3,
            "name": "Z-Drugs",
            "learnItems":[],
            "testItems":[
                  {
                        "title":"Mechanism of Action",  
                        "question" : "Eszopiclone binds to this receptor",
                        "options" : [
                              "barbiturate", 
                              "benzodiazepine", 
                              "dopamine"
                        ],
                        "answer" : "benzodiazepine"
                  },
                  {
                        "title":"Mechanism of Action",  
                        "question" : "Normal circadian rhythm is re-established by a drug acting at this receptor",
                        "options" : [
                              "dopamine", 
                              "serotonin", 
                              "melatonin"
                        ],
                        "answer" : "melatonin"
                  },
                  {
                        "title":"Mechanism of Action",  
                        "question" : "Eszopiclone binds to the benzodiazepine receptor and potentiates",
                        "options" : [
                              "GABA", 
                              "Glutamate", 
                              "dopamine"
                        ],
                        "answer" : "GABA"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Normal circadian rhythm is re-established at the melatonin receptor when this drug acts upon it",
                        "options" : [
                              "zolpidem", 
                              "mirtazapine", 
                              "ramelteon "
                        ],
                        "answer" : "ramelteon"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "This drug has the longest half-life",
                        "options" : [
                              "Zolpidem", 
                              "Eszopiclone", 
                              "Ramelteon"
                        ],
                        "answer" : "Eszopiclone"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "This drug has the longest potency",
                        "options" : [
                              "Zolpidem", 
                              "Eszopiclone", 
                              "Ramelteon"
                        ],
                        "answer" : "Zolpidem"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "This drug is used to induce sleep",
                        "options" : [
                              "zolpidem", 
                              "zaleplon", 
                              "eszopiclone"
                        ],
                        "answer" : "zolpidem"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Zolpidem is metabolized slower by ",
                        "options" : [
                              "Men", 
                              "Women"
                        ],
                        "answer" : "Women"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "John Smith is waking up regularly in the middle of the night. A good therapy for him would be",
                        "options" : [
                              "zolpidem",
                              "eszopiclone", 
                              "zaleplon"
                        ],
                        "answer" : "zaleplon"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Both the a1 and a1 benzodiazepine receptor is acted upon by ",
                        "options" : [
                              "eszopiclone", 
                              "zaleplon", 
                              "zolpidem "
                        ],
                        "answer" : "eszopiclone"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Z-drugs primarily cause",
                        "options" : [
                              "sedation", 
                              "amnesia", 
                              "anxiety relief"
                        ],
                        "answer" : "sedation"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Z-drugs bind primarily to this receptor",
                        "options" : [
                              "GABA", 
                              "benzodiazepine", 
                              "barbiturate "
                        ],
                        "answer" : "benzodiazepine"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Z-drugs bind primarily to benzodiazepine's subunit receptor:",
                        "options" : [
                              "benzodiazepine", 
                              "alpha1", 
                              "alpha2",
                              "beta"
                        ],
                        "answer" : "alpha1"
                  },
                  {
                        "title":"Side-Effects",  
                        "question" : "Z drugs are not effective antianxiety drugs because they bind primarily to the alpha1 subunit of benzodiazepine not the subunit:",
                        "options" : [
                              "benzodiazepine", 
                              "alpha1", 
                              "alpha2",
                              "beta"
                        ],
                        "answer" : "alpha2"
                  }
            ], 
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Diazepam", "content": "", "imagePath": "/molecular.PNG" },
                              {"title": "Lorazepam", "content": "", "imagePath": "/molecular.PNG" }, 
                              {"title": "Temazepam", "content": "", "imagePath": "/molecular.PNG" },
                              {"title": "Midazolam", "content": "", "imagePath": "/molecular.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Pharmokinetic",  
                        "sections" : [
                              {"title": "Absorption", "content": "" },
                              {"title": "Distribution", "content": "" }, 
                              {"title": "Metabolism", "content": "" },
                              {"title": "Excretion", "content": ""  }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "Mechanism of Action", "content": "" },
                              {"title": "Pharmacological Action", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ]
      },
      {
            "id": 4,
            "name": "Anticonvulsants",
            "learnItems":[],
            "testItems":[
                  {
                        "title":"",  
                        "question" : "Antiepileptic drugs primarily reduce this activity",
                        "options" : [
                              "excitatory", 
                              "inhibitory "
                        ],
                        "answer" : "excitatory"
                  },
                  {
                        "title":"",  
                        "question" : "Consciousness is impaired for 30 seconds - 2 minutes by this seizure type: ",
                        "options" : [
                              "partial", 
                              "complex partial",
                              "absence "
                        ],
                        "answer" : "complex partial"
                  },
                  {
                        "title":"",  
                        "question" : "Antiepileptic drugs targeting sodium channels block",
                        "options" : [
                              "Sodium efflux",
                              "normal action potentials",
                              "epileptiform discharges"
                        ],
                        "answer" : "epileptiform discharges"
                  },
                  {
                        "title":"",  
                        "question" : "Antiepileptic drugs primarily enhance this activity",
                        "options" : [
                              "excitatory", 
                              "inhibitory "
                        ],
                        "answer" : "inhibitory"
                  },
                  {
                        "title":"",  
                        "question" : "Felbamate is an antiepileptic that blocks these receptors",
                        "options" : [
                              "AMPA", 
                              "dopamine",
                              "GABA",
                              "NMDA"
                        ],
                        "answer" : "GABA"
                  },
                  {
                        "title":"",  
                        "question" : "Reducing seizures and weight is possible with this anticonvulsant drug",
                        "options" : [
                              "topiramate", 
                              "valproic acid",
                              "gabapentin"
                        ],
                        "answer" : "topiramate"
                  },
                  {
                        "title":"",  
                        "question" : "Ethosuximide acts by inhibiting the activity of these channels",
                        "options" : [
                              "Calcium",
                              "Sodium",
                              "Chloride",
                              "Potassium"
                        ],
                        "answer" : "Calcium"
                  },
                  {
                        "title":"",  
                        "question" : "Ethosuximide is only used for this type of seizure",
                        "options" : [
                              "complex",
                              "partial",
                              "absence "
                        ],
                        "answer" : "absence"
                  },
                  {
                        "title":"",  
                        "question" : "This drug induces its own metabolism",
                        "options" : [
                              "Phenytoin", 
                              "Carbamazepine",
                              "Gabapentin"
                        ],
                        "answer" : "Carbamazepine"
                  },
                  {
                        "title":"",  
                        "question" : "Steven's Johnson syndrome is a rare but serious side effect of",
                        "options" : [
                              "Levetiracetam", 
                              "Lamotrigine",
                              "Carbamazepine"
                        ],
                        "answer" : "Lamotrigine"
                  },
                  {
                        "title":"",  
                        "question" : "Dizziness and somnolence is the most common side effect of",
                        "options" : [
                              "Phenytoin & Gabapentin", 
                              "Pregabalin & Phenobarbital",
                              "Pregabalin & Gabapentin",
                              "Phenobarbital & Gabapentin"
                        ],
                        "answer" : "Pregabalin & Gabapentin"
                  },
                  {
                        "title":"",  
                        "question" : "This binds to a synaptic vesicle protein and reduces presynaptic neurotransmitter release mediated by Ca2+",
                        "options" : [
                              "Levetiracetam", 
                              "Lamotrigine",
                              "topiramate"
                        ],
                        "answer" : "Levetiracetam"
                  },
                  {
                        "title":"",  
                        "question" : "Carbamazepine can be administered most safely without interaction with",
                        "options" : [
                              "lorazepam", 
                              "phenytoin",
                              "diazepam"
                        ],
                        "answer" : "diazepam"
                  },
                  {
                        "title":"",  
                        "question" : "This is an irreversible inhibitor of GABA transaminase",
                        "options" : [
                              "Gabapentin", 
                              "Pregabalin",
                              "Valproic acid",
                              "Vigabatrin "
                        ],
                        "answer" : "Vigabatrin"
                  }

            ], 
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Diazepam", "content": "Long acting (30 - 60 hours)", "imagePath": "/molecular.PNG" },
                              {"title": "Lorazepam", "content": "Intermediate acting (8-20 hours)", "imagePath": "/molecular.PNG" }, 
                              {"title": "Temazepam", "content": "Intermediate acting (8-20 hours)", "imagePath": "/molecular.PNG" },
                              {"title": "Midazolam", "content": "Short acting (1.5-5 hours)", "imagePath": "/molecular.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Pharmokinetic",  
                        "sections" : [
                              {"title": "Absorption", "content": "" },
                              {"title": "Distribution", "content": "" }, 
                              {"title": "Metabolism", "content": "" },
                              {"title": "Excretion", "content": ""  }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "Mechanism of Action", "content": "" },
                              {"title": "Pharmacological Action", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ]
      },
      {
            "id": 5,
            "name": "SRIs",
            "learnItems":[
                  {
                        "title":"SAR Requirements",  
                        "name" : "Phenoxyphenylalkyl Amines",
                        "imagePath" : "slide3.PNG",
                        "colorLocationAssociations" : [
                              {"color": "green", "location": "Basic Nitrogen", "description" : "Basic nitrogen: protonated at physiological pH; pKa 8.7−9.8" },
                              {"color": "deeppink", "location": "Electron-withdrawing group", "description" : "Electron-withdrawing group: para or meta substitution enhances binding affinity for SERT; while Ortho substitution (except CF3) enhances binding affinity for NET and results in NRI" },
                              {"color": "red", "location": "Phenoxy", "description" : "Phenoxy: distinguishes antidepressant and antihistamine activity (derived from diphenhydramine)." }
                        ]
                  },
                  {
                        "title":"Phenoxyphenylalkyl Amines Example",  
                        "name" : "Fluoxetine",
                        "imagePath" : "slide-5a.PNG",
                        "colorLocationAssociations" : [
                               {"color": "green", "location": "Basic Nitrogen", "description" : "Basic nitrogen: protonated at physiological pH; pKa 8.7−9.8" },
                              {"color": "deeppink", "location": "Electron-withdrawing group", "description" : "Electron-withdrawing group: para or meta substitution enhances binding affinity for SERT; while Ortho substitution (except CF3) enhances binding affinity for NET and results in NRI" },
                              {"color": "red", "location": "Phenoxy", "description" : "Phenoxy: distinguishes antidepressant and antihistamine activity (derived from diphenhydramine)." }
                        ]
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Phenylalkyl Amines",
                        "imagePath" : "slide4.PNG",
                        "colorLocationAssociations" : [
                              {"color": "green", "location": "Basic Nitrogen", "description" : "Basic nitrogen: protonated at physiological pH; pKa 9.5" },
                              {"color": "deeppink", "location": "Chlorine", "description" : "Chlorine: enhances SERT selectivity" }
                        ]
                  },
                  {
                        "title":"Phenylalkyl Amines Example",  
                        "name" : "Sertraline",
                        "imagePath" : "slide-5b.PNG",
                        "colorLocationAssociations" : [
                              {"color": "green", "location": "Basic Nitrogen", "description" : "Basic nitrogen: protonated at physiological pH; pKa 9.5" },
                              {"color": "deeppink", "location": "Chlorine", "description" : "Chlorine: enhances SERT selectivity" }
                        ]
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide7.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Decrease",
                        "explanation" : "The presence of an EWG (CF3) increases SERT activity of phenoxyphenylalkyl amines"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide8.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Increase",
                        "explanation" : "The presence of the phenoxy (O directly attached to phenyl ring) distinguishes SRIs from diphenhydramine"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide9.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Increase",
                        "explanation" : "The S isomer of fluoxetine is 100x more selective for SERT"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide10.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Decrease",
                        "explanation" : "Ortho EWG substitution results in NRI and decreases SERT affinity"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide12.PNG",
                        "question" : "Which of these 3 antidepressants has major side effects as GI upset and sexual dysfunction?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 1",
                        "explanation" : "Paroxetine is an SRI, which commonly shows these adverse events"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide13.PNG",
                        "question" : "Which of these 3 antidepressants is most selective for SERT?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : "Sertraline is an SRI, which is selective for SERT. Compound 1 is an NRI and compound 2 is a secondary amine TCA, which is more selective for NET."
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide15.PNG",
                        "question" : "Predict whether the metabolites will be active or inactive for the compounds (1, 3)",
                        "options" : [ 
                              "Active, Active",
                              "Active, Inactive",
                              "Inactive, Active",
                              "Inactive, Inactive"
                        ],
                        "answer" : "Inactive, Active",
                        "explanation" : ""
                  }
            ],
            "testItems":[
                  {
                        "title":"",  
                        "question" : "Escitalopram, fluoxetine, sertraline, and citalopram are examples of:",
                        "options" : [
                              "Tricyclic antidepressants",
                              "Atypical antidepressants",
                              "Norepinephrine Reuptake Inhibitors",
                              "Serotonin Reuptake Inhibitors"
                        ],
                        "answer" : "Serotonin Reuptake Inhibitors"
                  },
                  {
                        "title":"",  
                        "question" : "___________ are the most widely prescribed antidepressants",
                        "options" : [
                              "TCAs",
                              "SRIs",
                              "Lithium",
                              "SNRIs"
                        ],
                        "answer" : "SRIs"
                  },
                  {
                        "title":"",  
                        "question" : "__________ inhibits CYPs more significantly than other _______",
                        "options" : [
                              "(Escitalopram, TCAs)",
                              "(Sertraline, Atypical Antidepressants)",
                              "(Fluoxetine, SRIs)",
                              "(Citalopram, NRIs)"
                        ],
                        "answer" : "(Fluoxetine, SRIs)"
                  },
                  {
                        "title":"",  
                        "question" : "The most common adverse effects of SRIs GI and ________________",
                        "options" : [
                              "sexual side effects",
                              "orthostatic hypotension",
                              "constipation",
                              "drowsiness"
                        ],
                        "answer" : "sexual side effects"
                  },
                  {
                        "title":"",  
                        "question" : "SRIs have common drug interactions with _______ and can cause elevated levels of __________",
                        "options" : [
                              "(Acetylcholinesterase inhibitors, Acetylcholine)",
                              "(Anticonvulsants, Norepinephrine)",
                              "(Antibiotics, Dopamine)",
                              "(MAOIs, Serotonin)"
                        ],
                        "answer" : "(MAOIs, Serotonin)"
                  },
                  {
                        "title":"",  
                        "question" : "_________ can be recognized with side effects such as increased heart rate and diarrhea",
                        "options" : [
                              "Orthostatic Hypotension,",
                              "Antihistaminic Effects,",
                              "Serotonin Syndrome",
                              "Antimuscarinic Effects"
                        ],
                        "answer" : "Serotonin Syndrome"
                  },
                  {
                        "title":"",  
                        "question" : "SRIs are ________ tolerated than TCA",
                        "options" : [
                              "more",
                              "less",
                              "equally"
                        ],
                        "answer" : "more"
                  },
                  {
                        "title":"",  
                        "question" : "Abrupt withdrawal of SRIs can cause:",
                        "options" : [
                              "physical dependence",
                              "rebound effect",
                              "hangover",
                              "medullary depression"
                        ],
                        "answer" : "rebound effect"
                  }
            ], 
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Paroxetine (Pheno)", "imagePath": "paroxetine.PNG" },
                              {"title": "Escitalopram (Pheno)", "imagePath": "escitalopram.PNG" }, 
                              {"title": "Fluoxetine (Pheno)", "imagePath": "fluoxetine.PNG" },
                              {"title": "Sertraline (Pheny)", "imagePath": "sertraline.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics - Phenoxyphenylalkyl Amines",  
                        "sections" : [
                              {"title": "Phenoxyphenylalkyl Amines", "imagePath": "sarCharacteristics-pheno.PNG" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics - Phenylalkyl Amine",  
                        "sections" : [
                              {"title": "Phenylalkyl Amine", "imagePath": "sarCharacteristics-pheny.PNG" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "Mechanism of Action", "imagePath": "mechanismAction.PNG" },
                              {"title": "Explanation", "content": "" },
                              {"title": "Acute SRI Use", "content": "" },
                              {"title": "Chronic SRI Use", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ],
             "exampleReview":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Paroxetine (Pheno)", "imagePath": "paroxetine.PNG" },
                              {"title": "Escitalopram (Pheno)", "imagePath": "escitalopram.PNG" }, 
                              {"title": "Fluoxetine (Pheno)", "imagePath": "fluoxetine.PNG" },
                              {"title": "Sertraline (Pheny)", "imagePath": "sertraline.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics - Phenoxyphenylalkyl Amines",  
                        "sections" : [
                              {"title": "Phenoxyphenylalkyl Amines", "imagePath": "sarCharacteristics-pheno.PNG" },
                              {"title": "Basic nitrogen: ", "content": "protonated at physiological pH; pKa 8.7−9.8" },
                              {"title": "Electron-withdrawing group: ", "content": "para or meta substitution enhances binding affinity for SERT. -Ortho substitution (except CF3) enhances binding affinity for NET and results in NRI" }, 
                              {"title": "Phenoxy:", "content": "distinguishes antidepressant and antihistamine activity (derived from diphenhydramine)" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics - Phenylalkyl Amine",  
                        "sections" : [
                              {"title": "Phenylalkyl Amine", "imagePath": "sarCharacteristics-pheny.PNG" },
                              {"title": "Basic Nitrogen", "content": "Protonated at physiological pH; pKa 9.5" },
                              {"title": "Chlorine", "content": "enhances SERT selectivity" }
                        ]
                  },
                  {
                        "title": "Action",  
                        "sections" : [
                              {"title": "Mechanism of Action", "imagePath": "mechanismAction.PNG" },
                              {"title": "Explanation", "content": "Blocks Serotonin Transporter (SERT) on pre-synaptic neuron resulting in increased serotonin in the synapse which is available to bind to post synaptic serotonin receptors." },
                              {"title": "Acute SRI Use", "content": "1. Drug blocks 5-HT re-update (SERT) 2. Auto receptor (5-HT1A) activity decreases 3. 5-HT release decreases" },
                              {"title": "Chronic SRI Use", "content": "1. Auto receptor (5-HT1A) function is lost 2. 5-HT release returns to normal 3. Now serotonin in synapse is greatly increased" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "Nausea & GI symptoms, Sexual effects (decreased libido & sexual dysfunction), Mild restlessness, Mild headaches, Mild Insomnia" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "Depression, OCD, panic disorder, anxiety" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "SRIs compete with metabolism of other drugs, Never use in combo with MAOIs (MAOIs inhibit breakdown of SRIs and could lead to overdose of serotonin in the brain)" }
                        ]
                  }
            ]
      },
      {
            "id": 6,
            "name": "SNRIs",
            "learnItems":[
                  {
                        "title":"Helpful Strucures to Know",  
                        "name" : "Duloxetine",
                        "imagePath" : "slide-23a.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "None", "description" : "Serotonin and Norepinephrine Reuptake Inhibitors do not have any Structure Activity Requirements but these are some helpful structures to be familiar with." }
                        ]
                  },
                  {
                        "title":"Helpful Strucures to Know",  
                        "name" : "Venlafaxine",
                        "imagePath" : "slide-23b.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "None", "description" : "Serotonin and Norepinephrine Reuptake Inhibitors do not have any Structure Activity Requirements but these are some helpful structures to be familiar with." }
                        ]
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide25.PNG",
                        "question" : "Which of these 3 antidepressants is active at both SERT and NET?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 2",
                        "explanation" : "Duloxetine is an SNRI, which is active at SERT and NET. Compound 1 is SRI and Compound 3 is bupropion, which weakly blocks DAT and NET"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide26.PNG",
                        "question" : "Which of these 3 antidepressants is considered activating and may raise blood pressure?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : " Venlafaxine is an SNRI, which is known to be activating"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Clinical Case Study ",
                        "imagePath" : "slide28.PNG",
                        "question" : "Alfred Smith is 80-year old male suffering from depression. He is currently taking paroxetine, but it is not helping. What one compound would you recommend he try next?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : "Compound 1 is an SRI, which he was currently taking and not helping. Compound 2 is a tertiary amine TCA, which acts as a SNRI and would be helpful, but leads to adverse effects such as sedation and hypotension so not recommended in elderly. Compound 3 (venlafaxine) is best choice as it is SNRI, with few adverse effects."
                  }
            ],
            "testItems":[
                  {
                        "title":"",  
                        "question" : "Venlafaxine and duloxetine are examples of: ",
                        "options" : [
                              "Tricyclic Antidepressants",
                              "Atypical Antidepressants",
                              "Serotonin-Norepinephrine Reuptake Inhibitors",
                              "Selective Serotonin Reuptake Inhibitors"
                        ],
                        "answer" : "Serotonin-Norepinephrine Reuptake Inhibitors"
                  },
                  {
                        "title":"",  
                        "question" : "SNRI’s have _________ effects such as agitation",
                        "options" : [
                              "seratonergic",
                              "noradrenergic",
                              "histaminergic",
                              "cholinergic"
                        ],
                        "answer" : "noradrenergic"
                  },
                  {
                        "title":"",  
                        "question" : "(venlafaxine/duloxetine) is more potent than (venlafaxine/duloxetine)",
                        "options" : [
                              "(venlafaxine, duloxetine)",
                              "(duloxetine, venlafaxine)"
                        ],
                        "answer" : "(venlafaxine, duloxetine)"
                  },
                  {
                        "title":"",  
                        "question" : "SNRI’s are similar to TCA potency, have (less/more) side effects, and (faster/slower) than SRI alone",
                        "options" : [
                              "(less, faster)",
                              "(more, slower)",
                              "(more, faster)",
                              "(less, slower)"
                        ],
                        "answer" : "(less, faster)"
                  },
                  {
                        "title":"",  
                        "question" : "_________ has an active metabolite",
                        "options" : [
                              "Duloxetine",
                              "Sibutramine",
                              "Venlafaxine",
                              "Milnacipran"
                        ],
                        "answer" : "Venlafaxine"
                  },
                  {
                        "title":"",  
                        "question" : "BONUS: Venlafaxine's active metabolite's name is:",
                        "options" : [
                              "Ansofaxine",
                              "Duloxetine",
                              "Atomoxetine",
                              "Desvenlafaxine"
                        ],
                        "answer" : "Desvenlafaxine"
                  }
            ], 
            "reviewItems":[]
      },
      {
            "id": 7,
            "name": "Tricyclic-Antidepressants",
            "learnItems":[
                  {
                        "title":"SAR Requirements",  
                        "name" : "Tertiary Amines",
                        "imagePath" : "slide34.PNG",
                        "colorLocationAssociations" : [
                              {"color": "red", "location": "Linker of 3 carbons", "description" : "Linker of 3 carbons between tricyclic ring system and basic nitrogen. Branching from linker decreases binding affinity for SERT and NET. Unsaturation of linker is tolerated." },
                              {"color": "deeppink", "location": "R→ CH3", "description" : "R→ CH3, tertiary amine imparts selectivity for SERT" },
                              {"color": "blue", "location": "R’→ Cl or CN (EWG)", "description" : "R’→ Cl or CN (EWG) enhances binding affinity for SERT" },
                              {"color": "green", "location": "Y→ can be C or N", "description" : "Y→ can be C or N" },
                              {"color": "purple", "location": "Conformationally rigid [6.7.6]-fused ring system", "description" : "Conformationally rigid [6.7.6]-fused ring system - 7 membered ring in the middle is not coplanar; results in twisted shape" }
                        ]
                  },
                  {
                        "title":"Tertiary Amines Example Compound",  
                        "name" : "Clomipramine",
                        "imagePath" : "slide-36a.PNG",
                        "colorLocationAssociations" : []
                  },
                  {
                        "title":"SAR Requirements",  
                        "name" : "Secondary Amines",
                        "imagePath" : "slide35.PNG",
                        "colorLocationAssociations" : [
                              {"color": "red", "location": "Linker of 3 carbons", "description" : "Linker of 3 carbons between tricyclic ring system and basic nitrogen. Branching from linker decreases binding affinity for SERT and NET. Unsaturation of linker is tolerated." },
                              {"color": "deeppink", "location": "R→ CH3", "description" : "R→ H, secondary amine imparts selectivity for NET" },
                              {"color": "blue", "location": "R’→ Cl or CN (EWG)", "description" : "R’→ no substitution decreases SERT preference" },
                              {"color": "green", "location": "Y→ can be C or N", "description" : "Y→ can be C or N" },
                              {"color": "purple", "location": "Conformationally rigid [6.7.6]-fused ring system", "description" : "Conformationally rigid [6.7.6]-fused ring system - 7 membered ring in the middle is not coplanar; results in twisted shape" }
                        ]
                  },
                  {
                        "title":"Secondary Amines Example Compound",  
                        "name" : "Nortriptyline",
                        "imagePath" : "slide-36b.PNG",
                        "colorLocationAssociations" : []
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide38.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Decrease",
                        "explanation" : "Tertiary→ Secondary amine decreases binding affinity for SERT"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Activity Change",
                        "imagePath" : "slide39.PNG",
                        "question" : "Would the following change to the compound increase, decrease, or have no effect upon activity at SERT?",
                        "options" : [
                              "Increase", 
                              "Decrease", 
                              "No Effect"
                        ],
                        "answer" : "Increase",
                        "explanation" : "Presence of EWG (Cl) enhances binding affinity for SERT"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide41.PNG",
                        "question" : "Which of these 3 antidepressants is active at both SERT and NET?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 2",
                        "explanation" : "Compound 2, amitriptyline is a tertiary TCA, which is active at SERT and NET. Compound 1 is SRI and Compound 3 is a secondary TCA, only active at NET"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide42.PNG",
                        "question" : "Which of these 3 antidepressants causes significant dry mouth, constipation, and sedation?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 1",
                        "explanation" : "Compound 1, clomipramine is a tertiary TCA, which is can bind to muscarinic and histamine receptors resulting in off target adverse effects. Compound 2 is a SRI and does not cause these adverse effects. Compound 3 is a mirtazepine and while it can cause sedation, it does not display anticholinergic effects such as dry mouth and constipation."
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide44.PNG",
                        "question" : "Predict whether the metabolites will be active or inactive for the compound products. Would amitriptyline be an ideal antidepressant for the elderly?",
                        "options" : [ 
                              "Active, Active, Yes",
                              "Active, Inactive, No", 
                              "Inactive, Inactive, No",
                              "Inactive, Active, Yes"
                        ],
                        "answer" : "Active, Inactive, No",
                        "explanation" : "Aamitriptyline causes anticholinergic effects, therefore it is not an ideal antidepressant for the elderly."
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide45.PNG",
                        "question" : "Predict whether the metabolites will be active or inactive for the compound products",
                        "options" : [ 
                              "Active, Active",
                              "Active, Inactive", 
                              "Inactive, Inactive",
                              "Inactive, Active"
                        ],
                        "answer" : "Active, Inactive",
                        "explanation" : "No explanation for this item."
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Predict Metabolite Activity",
                        "imagePath" : "slide46.PNG",
                        "question" : "Predict whether the metabolites will be active or inactive for the compound product. Is nortriptyline considered an SNRI or NRI?",
                        "options" : [ 
                              "Active, NRI",
                              "Active, SNRI", 
                              "Inactive, NRI",
                              "Inactive, SNRI"
                        ],
                        "answer" : "Inactive, NRI",
                        "explanation" : "Nortriptyline is a secondary TCA so it is more selective for NET."
                  }
            ],
            "testItems":[
                  {
                        "title":"",  
                        "question" : "Tertiary TCAs have slightly greater selectivity for blockade of (Norepinephrine/Serotonin) reuptake over (Norepinephrine/Serotonin) reuptake",
                        "options" : [
                              "(Norepinephrine, Serotonin)",
                              "(Serotonin, Norepinephrine)"
                        ],
                        "answer" : "(Serotonin, Norepinephrine)"
                  },
                  {
                        "title":"",  
                        "question" : "Secondary TCA’s, such as (Nortriptyline/Amitriptyline) have greater selectivity for blockade of (Norepinephrine/Serotonin)",
                        "options" : [
                              "(Nortriptyline, Norepinephrine)",
                              "(Nortriptyline, Serotonin)",
                              "(Amitriptyline, Norepinephrine)",
                              "(Amitriptyline, Serotonin)"
                        ],
                        "answer" : "(Nortriptyline, Norepinephrine)"
                  },
                  {
                        "title":"",  
                        "question" : "TCA adverse effects include _____________ effects such as dry eyes and mouth",
                        "options" : [
                              "adrenergic",
                              "antihistaminic",
                              "anticholinergic",
                              "antimuscarinic"
                        ],
                        "answer" : "antimuscarinic"
                  },
                  {
                        "title":"",  
                        "question" : "Onset of action for TCA’s takes 2-3:",
                        "options" : [
                              "months",
                              "weeks",
                              "days",
                              "minutes"
                        ],
                        "answer" : "weeks"
                  },
                  {
                        "title":"",  
                        "question" : "Side effects include sexual dysfunction, constipation, and: ",
                        "options" : [
                              "prominent GI effects",
                              "sedation",
                              "migraines",
                              "blood disorders"
                        ],
                        "answer" : "sedation"
                  }
            ], 
            "reviewItems":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Amitriptyline (Tertiary)", "imagePath": "review-Amitriptyline.PNG" },
                              {"title": "Nortriptyline (Secondary)", "imagePath": "review-Nortriptyline.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "Example Compound", "imagePath": "review-sar.PNG" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" },
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" }, 
                              {"title": "", "content": "" },  
                              {"title": "", "content": "" }
                        ]
                  },
                  {
                        "title": "Mechanism of Action",  
                        "sections" : [
                              {"title": "MOA", "imagePath": "moa-TCAs.PNG" },
                              {"title": "Explanation", "content": "" }
                        ]
                  },
                  {
                        "title": "Side-Effects",  
                        "sections" : [
                              {"title": "Side-Effects", "content": "" }
                        ]
                  },
                  {
                        "title": "Uses",  
                        "sections" : [
                              {"title": "Uses", "content": "" }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "" }
                        ]
                  }
            ],
            "exampleReview":[
                  {
                        "title": "Drugs",  
                        "sections" : [
                              {"title": "Amitriptyline (Tertiary)", "imagePath": "review-Amitriptyline.PNG" },
                              {"title": "Nortriptyline (Secondary)", "imagePath": "review-Nortriptyline.PNG" }
                        ]
                  },
                  {
                        "title": "SAR Characteristics",  
                        "sections" : [
                              {"title": "Example Compound", "imagePath": "review-sar.PNG" },
                              {"title": "Linker of 3 carbons", "content": "Linker of 3 carbons between tricyclic ring system and basic nitrogen. Branching from linker decreases binding affinity for SERT and NET. Unsaturation of linker is tolerated." },
                              {"title": "R→ CH3, tertiary amine", "content": "R→ CH3, tertiary amine imparts selectivity for SERT" },
                              {"title": "R→ H, secondary amine", "content": "R→ H, secondary amine imparts selectivity for NET" }, 
                              {"title": "R’→ Cl or CN (EWG)", "content": "R’→ Cl or CN (EWG) enhances binding affinity for SERT" }, 
                              {"title": "R’→ no substitution", "content": "R’→ no substitution decreases SERT preference" }, 
                              {"title": "Y→ can be C or N", "content": "Y→ can be C or N" },  
                              {"title": "Conformationally rigid [6.7.6]-fused ring system", "content": "Conformationally rigid [6.7.6]-fused ring system - 7 membered ring in the middle is not coplanar; results in twisted shape" }
                        ]
                  },
                  {
                        "title": "Mechanism of Action",  
                        "sections" : [
                              {"title": "MOA", "imagePath": "moa-TCAs.PNG" },
                              {"title": "Explanation", "content": "Block SERT & NET to inhibit seratonin and norepinephrine reuptake. Block muscarinic, Histamine H1, and Alpha adrenergic receptors" }
                        ]
                  },
                  {
                        "title": "Side-Effects",
                        "sections" : [
                              {"title": "Side-Effects", "content": "[Amitriptyline]: Sedation, Hypotension, Anti-Muscarinic, Weight Gain. [Nortiptyline]: No major side effects." }
                        ]
                  },
                  {
                        "title": "Notes",  
                        "sections" : [
                              {"title": "Notes", "content": "[Amitriptyline]: Can cause extreme CNS depression leading to death if OD. [Nortiptyline]: Selectively blocks NET with much more affinity than SERT." }
                        ]
                  }
            ]
      },
      {
            "id": 8,
            "name": "Atypical-Antidepressants",
            "learnItems":[
                  {
                        "title":"Useful Structures",  
                        "name" : "Trazodone",
                        "imagePath" : "slide-53a.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "none", "description" : "Circled parts of each structure are helpful to associate with the compounds. There are no SAR Requirements for Atypical Antidepressants" }
                        ]
                  },
                  {
                        "title":"Useful Structures",  
                        "name" : "Mirtazepine",
                        "imagePath" : "slide-53b.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "none", "description" : "Circled parts of each structure are helpful to associate with the compounds. There are no SAR Requirements for Atypical Antidepressants" }
                        ]
                  },
                  {
                        "title":"Useful Structures",  
                        "name" : "Bupropion",
                        "imagePath" : "slide-53c.PNG",
                        "colorLocationAssociations" : [
                              {"color": "black", "location": "none", "description" : "Circled parts of each structure are helpful to associate with the compounds. There are no SAR Requirements for Atypical Antidepressants" }
                        ]
                  },
                  {
                        "title":"Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide55.PNG",
                        "question" : "Which of these 3 antidepressants can also be used for smoking cessation?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 2",
                        "explanation" : "Bupropion"
                  },
                  {
                        "title":"Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide56.PNG",
                        "question" : "Which of these 3 antidepressants causes sedation by blocking histamine receptors?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : "Mirtazepine"
                  },
                  {
                        "title":"Practice Problem",  
                        "name" : "Compare Compounds",
                        "imagePath" : "slide57.PNG",
                        "question" : "Which of these 3 antidepressants can result in a hepatotoxic metabolite?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 2",
                        "explanation" : "Metabolism of Trazodone"
                  },
                  {
                        "title":"SAR Practice Problem",  
                        "name" : "Clinical Case Study ",
                        "imagePath" : "slide59.PNG",
                        "question" : "Mary Sue is 25-year old male suffering from depression. She complains of feeling tired and gaining weight with her last course of antidepressants. Which compound would you recommend her to try?",
                        "options" : [
                              "Compound 1", 
                              "Compound 2", 
                              "Compound 3"
                        ],
                        "answer" : "Compound 3",
                        "explanation" : "Compound 1 (trazodone) can cause sedation. Compound 2 (amitriptyline) can cause weight gain. Compound 3 (bupropion) would be a good alternative for this patient to prevent unwanted adverse effects."
                  }
            ],
            "testItems":[
                  {
                        "title":"",  
                        "question" : "Significant side effect of both trazodone and mirtazepine is: ",
                        "options" : [
                              "orthostatic hypotension",
                              "sedation",
                              "constipation",
                              "sexual effects"
                        ],
                        "answer" : "sedation"
                  },
                  {
                        "title":"",  
                        "question" : "Trazodone works by blocking the ______ serotonin receptor and being an agonist at the _______ serotonin receptor",
                        "options" : [
                              "(5HT_1A, 5HT_2A)",
                              "(5HT_1D, 5HT_2B)",
                              "(5HT_2A, 5HT_1A)",
                              "(5HT_2B, 5HT_1D)"
                        ],
                        "answer" : "(5HT_2A, 5HT_1A)"
                  },
                  {
                        "title":"",  
                        "question" : "Mirtazapine blocks a serotonin receptor and a ________ receptor",
                        "options" : [
                              "adrenergic",
                              "dopamine",
                              "histamine",
                              "muscarinic"
                        ],
                        "answer" : "histamine"
                  },
                  {
                        "title":"",  
                        "question" : "Buproprion has a potential for ___________ at high doses",
                        "options" : [
                              "seizures",
                              "dyskinesia",
                              "memory loss",
                              "respiratory depression"
                        ],
                        "answer" : "seizures"
                  },
                  {
                        "title":"",  
                        "question" : "__________ can cause increase appetite and weight gain while ___________ can have the opposite effect",
                        "options" : [
                              "(Mirtazapine, Buproprion)",
                              "(Buproprion, Mirtazapine)",
                              "(Trazodone, Buproprion)",
                              "(Buproprion, Trazodone)"
                              
                        ],
                        "answer" : "(Trazodone, Buproprion)"
                  },
                  {
                        "title":"",  
                        "question" : "______________ can be used a sleep aid independent of its antidepressant activity",
                        "options" : [
                              "Fluoxetine",
                              "Mirtazapine",
                              "Buproprion",
                              "Trazadone"
                        ],
                        "answer" : "Trazadone"
                  }
            ],
             "reviewItems":[
                  {
                        "title": "Atypical Antidepressants (Trazodone)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "trazodone.PNG", "content": "None"},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "Atypical Antidepressants (Mirtazapine)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "mirtazapine.PNG", "content": "None"},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "Atypical Antidepressants (Bupropion)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "bupropion.PNG", "content": "None"},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "SNRIs & SRIs (Venlafaxine)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "venlafaxine.PNG", "content": ""},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "SRIs (Escitalopram, Fluoxetine, Sertraline)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "sri-sar.PNG", "content": ""},
                              {"title": "Phenoxyphenylalkyl SAR", "content": ""},
                              {"title": "Phenylalkyl SAR", "content": ""},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "Tricyclic Antidepressants (Amitriptyline & Nortriptyline)",  
                        "sections" : [
                              {"title": "MOA", "content": "" },
                              {"title": "SAR", "imagePath": "triptyline.PNG", "content": ""},
                              {"title": "SAR Explained", "content": ""},
                              {"title": "Side Effects", "content": ""}
                        ]
                  },
                  {
                        "title": "THEORIES OF DEPRESSION",  
                        "sections" : [
                              {"title": "Monoamine Theory", "content": ""},
                              {"title": "Neurotrophic Theory", "content": ""}
                        ]
                  },
                  {
                        "title": "LOW NERUOTRANSMITTER LEVELS",  
                        "sections" : [
                              {"title": "Low serotonin", "content": ""},
                              {"title": "Low norepinephrine", "content": ""},
                              {"title": "Low dopamine", "content": ""}
                        ]
                  },
                  {
                        "title": "ACTIVATION OF RECEPTORS",  
                        "sections" : [
                              {"title": "5-HT", "content": ""},
                              {"title": "Adrenergic", "content": ""},
                              {"title": "Antihistamine H1", "content": ""},
                              {"title": "Alpha1-Adrenergic", "content": ""}
                        ]
                  }

            ],                     
            "exampleReview":[
                  {
                        "title": "Atypical Antidepressants (Trazodone)",  
                        "sections" : [
                              {"title": "MOA", "content": "Blocks SERT and alpha1-adrenergic receptor. Agonist at 5-HT1A on post-synaptic neuron." },
                              {"title": "SAR", "imagePath": "trazodone.PNG", "content": "None"},
                              {"title": "Side Effects", "content": "[Major]: Sedation. [Minor]: GI, Weight Gain."}
                        ]
                  },
                  {
                        "title": "Atypical Antidepressants (Mirtazapine)",  
                        "sections" : [
                              {"title": "MOA", "content": "Blocks H1 histamine receptor, 5HT2 receptor and alpha2-adrendergic receptor. Agonist at 5HT1A on post synaptic neuron." },
                              {"title": "SAR", "imagePath": "mirtazapine.PNG", "content": "None"},
                              {"title": "Side Effects", "content": "[Major]: Sedation. [Minor]: Weight Gain"}
                        ]
                  },
                  {
                        "title": "Atypical Antidepressants (Bupropion)",  
                        "sections" : [
                              {"title": "MOA", "content": "Blocks DAT and NET resulting in increased dopamine and NE in extracellular space - dopamine acts on reward pathway to improve mood." },
                              {"title": "SAR", "imagePath": "bupropion.PNG", "content": "None"},
                              {"title": "Side Effects", "content": "[Major]: Insomnia, Agitation. [Minor]: Nausea, Dry Mouth"}
                        ]
                  },
                  {
                        "title": "SNRIs & SRIs (Venlafaxine)",  
                        "sections" : [
                              {"title": "MOA", "content": "Blocks SERT and NET resulting in increased levels of serotinin and norepinephrine in the synapse." },
                              {"title": "SAR", "imagePath": "venlafaxine.PNG", "content": "None"},
                              {"title": "Side Effects", "content": "[Major]: GI, Sexual Effect."}
                        ]
                  },
                  {
                        "title": "SRIs (Escitalopram, Fluoxetine, Sertraline)",  
                        "sections" : [
                              {"title": "MOA", "content": "Selectively blocks SERT on the pre-synaptic neuron resulting in increased levels of serotonin in the synapse and increased activation of 5-HT1A receptors on post-synaptic neuron." },
                              {"title": "SAR", "imagePath": "sri-sar.PNG", "content": ""},
                              {"title": "Phenoxyphenylalkyl SAR", "content": "[Basic nitrogen]: protonated at physiological pH; pKa 8.7−9.8. [Electron-withdrawing group]: para or meta substitution enhances binding affinity for SERT. [Phenoxy]: distinguishes antidepressant and antihistamine activity derived from diphenhydramine)"},
                              {"title": "Phenylalkyl SAR", "content": "[Basic nitrogen]: protonated at physiological pH; pKa 9.5. [Chlorine]: enhances SERT selectivity."},
                              {"title": "Side Effects", "content": "[Major]: GI, Sexual Effect."}
                        ]
                  },
                  {
                        "title": "Tricyclic Antidepressants (Amitriptyline & Nortriptyline)",  
                        "sections" : [
                              {"title": "MOA", "content": "Blocks SET and NET on pre-synaptic neuron resulting in increased levels of serotonin and norepinephrine in the synapse. Some also acts as antagonists at 5HT2, Alpha1-adrenergic, histamine and muscarinic receptors." },
                              {"title": "SAR", "imagePath": "triptyline.PNG", "content": ""},
                              {"title": "SAR Explained", "content": "[Linker of 3 carbons]: between tricyclic ring system and basic nitrogen. Branching from linker decreases binding affinity for SERT and NET. Unsaturation of linker is tolerated. [R→ CH3]: tertiary amine imparts selectivity for SERT. [R’→ Cl or CN (EWG)]: enhances binding affinity for SERT. [Y→ can be C or N]. [Conformationally rigid [6.7.6]-fused ring system]: 7 membered ring in the middle is not coplanar; results in twisted shape"},
                              {"title": "Side Effects", "content": "[Major]: Weight gain, GI, Sexual Effect."}
                        ]
                  },
                  {
                        "title": "THEORIES OF DEPRESSION",  
                        "sections" : [
                              {"title": "Monoamine Theory", "content": "Deficiency of 5-HT and NE transmission in the CNS"},
                              {"title": "Neurotrophic Theory", "content": "Decrease of Brain Derived Neurotophic Factor (BDNF) resulting in reduced neuroplasticity, decreased number of spines and thus, decreased neurotransmission."}
                        ]
                  },
                  {
                        "title": "LOW NERUOTRANSMITTER LEVELS",  
                        "sections" : [
                              {"title": "Low serotonin", "content": "Anxiety, panic, phobia"},
                              {"title": "Low norepinephrine", "content": "Decreased concentration, decreased working memory, decreased information processing, fatigue."},
                              {"title": "Low dopamine", "content": "Cognitive slowing, hypersomnia, anhedonia"}
                        ]
                  },
                  {
                        "title": "ACTIVATION OF RECEPTORS",  
                        "sections" : [
                              {"title": "5-HT", "content": "GI and Nausea, Sexual Effects (decreased libido, sexual dysfunction), Mild Restlessness, Headaches and Insomnia"},
                              {"title": "Adrenergic", "content": "Agitation (awakening), small increases in blood pressure and heart rate"},
                              {"title": "Antihistamine H1", "content": "Sedation"},
                              {"title": "Alpha1-Adrenergic", "content": "Hypotension"}
                        ]
                  }

            ]            
      }
]